Redmile Group as of June 30, 2024
Portfolio Holdings for Redmile Group
Redmile Group holds 63 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | 11.3 | $188M | 1.0M | 183.64 | |
| Amicus Therapeutics (FOLD) | 6.4 | $105M | 11M | 9.92 | |
| Nurix Therapeutics (NRIX) | 5.6 | $92M | 4.4M | 20.87 | |
| Stoke Therapeutics (STOK) | 3.9 | $64M | 4.7M | 13.51 | |
| Immunome (IMNM) | 3.6 | $59M | 4.9M | 12.10 | |
| Regenxbio Inc equity us cm (RGNX) | 3.2 | $54M | 4.6M | 11.70 | |
| Livanova SHS (LIVN) | 3.1 | $51M | 930k | 54.82 | |
| Replimune Group (REPL) | 3.0 | $50M | 5.6M | 9.00 | |
| Adc Therapeutics Sa SHS (ADCT) | 2.9 | $48M | 15M | 3.16 | |
| Kymera Therapeutics (KYMR) | 2.9 | $47M | 1.6M | 29.85 | |
| Scholar Rock Hldg Corp (SRRK) | 2.7 | $45M | 5.5M | 8.33 | |
| Zymeworks Del (ZYME) | 2.7 | $44M | 5.2M | 8.51 | |
| Fate Therapeutics (FATE) | 2.6 | $43M | 13M | 3.28 | |
| Cogent Biosciences (COGT) | 2.4 | $41M | 4.8M | 8.43 | |
| Beam Therapeutics (BEAM) | 2.4 | $40M | 1.7M | 23.43 | |
| Silence Therapeutics Ads (SLN) | 2.3 | $38M | 2.0M | 19.00 | |
| Akero Therapeutics (AKRO) | 2.3 | $38M | 1.6M | 23.46 | |
| Biohaven (BHVN) | 2.3 | $38M | 1.1M | 34.71 | |
| Neurogene (NGNE) | 2.2 | $37M | 1.0M | 36.39 | |
| Pliant Therapeutics (PLRX) | 2.1 | $35M | 3.2M | 10.75 | |
| Catalent | 2.0 | $34M | 596k | 56.23 | |
| Annexon (ANNX) | 1.9 | $32M | 6.4M | 4.90 | |
| Boston Scientific Corporation (BSX) | 1.8 | $30M | 390k | 77.01 | |
| Ideaya Biosciences (IDYA) | 1.6 | $27M | 760k | 35.11 | |
| Celldex Therapeutics Com New (CLDX) | 1.6 | $27M | 719k | 37.01 | |
| Absci Corp (ABSI) | 1.5 | $25M | 8.3M | 3.08 | |
| Keros Therapeutics (KROS) | 1.5 | $25M | 553k | 45.70 | |
| Alx Oncology Hldgs (ALXO) | 1.5 | $24M | 4.0M | 6.03 | |
| 4d Molecular Therapeutics In (FDMT) | 1.4 | $23M | 1.1M | 20.99 | |
| Shattuck Labs (STTK) | 1.3 | $22M | 5.6M | 3.86 | |
| Igm Biosciences (IGMS) | 1.3 | $21M | 3.1M | 6.87 | |
| Immunovant (IMVT) | 1.1 | $19M | 720k | 26.40 | |
| Intuitive Surgical Com New (ISRG) | 1.1 | $18M | 40k | 444.85 | |
| Augmedix (AUGX) | 0.9 | $14M | 16M | 0.88 | |
| 89bio (ETNB) | 0.8 | $14M | 1.7M | 8.01 | |
| Ardelyx (ARDX) | 0.8 | $14M | 1.9M | 7.41 | |
| Stryker Corporation (SYK) | 0.8 | $13M | 40k | 340.25 | |
| Prime Medicine (PRME) | 0.6 | $11M | 2.1M | 5.14 | |
| Blueprint Medicines (BPMC) | 0.6 | $10M | 94k | 107.78 | |
| Establishment Labs Holdings Ord (ESTA) | 0.6 | $9.7M | 213k | 45.44 | |
| Nuvation Bio Com Cl A (NUVB) | 0.5 | $8.9M | 3.0M | 2.92 | |
| Entrada Therapeutics (TRDA) | 0.5 | $8.0M | 561k | 14.25 | |
| Ac Immune Sa SHS (ACIU) | 0.4 | $7.2M | 1.8M | 3.99 | |
| Verve Therapeutics (VERV) | 0.4 | $7.1M | 1.5M | 4.88 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $6.4M | 1.9M | 3.30 | |
| Cytokinetics Com New (CYTK) | 0.4 | $6.1M | 112k | 54.18 | |
| Ventyx Biosciences (VTYX) | 0.3 | $5.0M | 2.2M | 2.31 | |
| Boundless Bio (BOLD) | 0.2 | $4.0M | 1.0M | 3.87 | |
| Atara Biotherapeutics Com New (ATRA) | 0.2 | $3.8M | 452k | 8.50 | |
| Stereotaxis Com New (STXS) | 0.2 | $3.8M | 2.1M | 1.82 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.2 | $3.7M | 2.1M | 1.80 | |
| Adagio Therapeutics (IVVD) | 0.2 | $3.4M | 3.1M | 1.10 | |
| Cabaletta Bio (CABA) | 0.2 | $3.3M | 443k | 7.48 | |
| Gritstone Oncology Ord (GRTSQ) | 0.2 | $3.2M | 5.1M | 0.62 | |
| Allakos | 0.2 | $3.1M | 3.1M | 1.00 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $2.4M | 1.0M | 2.25 | |
| Rapt Therapeutics | 0.1 | $1.6M | 537k | 3.05 | |
| Allovir (ALVR) | 0.1 | $1.4M | 1.9M | 0.72 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.3M | 1.6M | 0.81 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $729k | 412k | 1.77 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.0 | $698k | 716k | 0.97 | |
| Hookipa Pharma Inc equity | 0.0 | $630k | 1.1M | 0.59 | |
| Alpha Teknova (TKNO) | 0.0 | $212k | 155k | 1.37 |
